Stockrabit · Analysts
Questions across 1 call

Sanjay Satapathy

Firm not listed in source transcripts

Natco Pharma Limited

Natco Pharma Limited CC-Jun24.pdf · 2024-08-13
Thanks a lot for the opportunity and congratulations once again for a fantastic result. So you have tried to answer this question about cash and its utilization in many which way. Can I just ask that if at all that will be the acquisition, will it be more to diversify your revenue stream so that you have lesser volatility or it will be more towards increasing your capability in R&D side?
My question is that, considering that your R&D unit is already delivering so nicely in terms of products and approvals, will you kind of use this big money to get into more of a capital intensive business like this PLI -driven API or something? I'm just try ing to kind of understand your thought process as to where the -- where the acquisition or investment will go into.